发明名称 |
METHODS FOR TREATMENT OF CARDIOMYOPATHY |
摘要 |
The methods and assays described herein related to the diagnosis, prognosis and treatment of cardiomyopathy, e.g. arrhythmia. As described herein, the inventors have discovered that certain compounds can be used to treat cardiomyopathies. These compounds are demonstrated herein to reduce expression of nppb, reduce bradycardia, improve contractility, and increase survival. Notably, provided herein is data demonstrating that administration of these compounds can both prevent the development of symptoms when administered prophylactically and reduce symptom severity in subjects where it is administered after the development of symptoms. |
申请公布号 |
US2016051514(A1) |
申请公布日期 |
2016.02.25 |
申请号 |
US201414782841 |
申请日期 |
2014.05.02 |
申请人 |
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ;BETH ISRAEL DEACONESS MEDICAL CENTER, INC. |
发明人 |
MACRAE Calum;SAFFITZ Jeffrey |
分类号 |
A61K31/404;A61K31/4015;G01N33/68;C07K14/47 |
主分类号 |
A61K31/404 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating cardiomyopathy, the method comprising administering a compound of Formula I: wherein R1 is optionally substituted heteroaromatic or —NR2R3; R2 is optionally substituted aryl; and R3 is H or alkyl. |
地址 |
Boston MA US |